CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Center Laboratories Inc Company Snapshot
Center Laboratories Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Center Laboratories Inc with three other companies in this sector in Taiwan: Lotus Pharmaceutical Co.,Ltd. (2017 sales of 6.42 billion Taiwanese Dollars [US$214.49 million] of which 90% was Western Medicine Manufacture), Yungshin Global Holding Corp (6.62 billion Taiwanese Dollars [US$221.13 million] of which 73% was Taiwan District), and Grape King Bio Ltd (9.39 billion Taiwanese Dollars [US$313.47 million] of which 86% was Direct Sales).

Sales Analysis. During the year ended December of 2017, sales at Center Laboratories Inc were 19.39 billion Taiwanese Dollars (US$647.49 million). This is an increase of 28.9% versus 2016, when the company's sales were 15.04 billion Taiwanese Dollars. This was the fifth consecutive year of sales increases at Center Laboratories Inc (and since 2012, sales have increased a total of 2,617%). Sales of Dongyuan Segment saw an increase of 46.8% in 2017, from 139.58 million Taiwanese Dollars to 204.93 million Taiwanese Dollars. Not all segments of Center Laboratories Inc experienced an increase in sales in 2017: sales of Biology Tech. Investment fell 11.1% to 1.52 million Taiwanese Dollars. (However, this segment's sales were only a very small portion of the company's overall sales). Center Laboratories Inc also experienced decreases in sales in Other Department (down 11.1% to 106.79 million Taiwanese Dollars) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Center Laboratories Inc
  Stock Performance Chart for Center Laboratories Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 68.90
(Figures in Taiwanese Dollars)
1 Week 2.1%   13 Weeks 8.5%  
4 Weeks 60.0%   52 Weeks 33.4%  
 
Center Laboratories Inc Key Data:
  Ticker: 4123 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 19,391,814,000
(Year Ending Jan 2018).
Employees: 322
  Currency: Taiwanese Dollars Market Cap: 21,637,838,300
  Fiscal Yr Ends: December Shares Outstanding: 314,047,000
  Share Type: Gu Closely Held Shares: 105,642,000
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.